ReviewEye (London, England)2022

An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma.

Faruque Ghanchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.